Related Experiment Videos
Matrix metalloproteinase-9 contributes to choroidal neovascularization
Vincent Lambert1, Carine Munaut, Maud Jost
1Laboratory of Tumor and Development Biology, University of Liège, Liège, Belgium. vincent.lambert@ulg.ac.be
The American Journal of Pathology
|October 9, 2002
Summary
Matrix metalloproteinase-9 (MMP-9) is upregulated during experimental choroidal neovascularization, a key factor in age-related macular degeneration. MMP-9 deficient mice showed reduced neovascularization, suggesting a therapeutic target.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Age-related macular degeneration (AMD) causes irreversible photoreceptor loss, with limited treatment options.
- Elevated matrix metalloproteinases (MMPs), particularly MMP-9 (gelatinase B), are implicated in neovascularization in ocular diseases like AMD.
Purpose of the Study:
- To investigate the role and temporal regulation of MMP-9 expression in experimental choroidal neovascularization (CNV).
- To assess the impact of MMP-9 deficiency on the development of laser-induced CNV.
Main Methods:
- Utilized transgenic mice with a beta-galactosidase reporter gene under the MMP-9 promoter.
- Employed RT-PCR analysis on laser pressure catapulting-microdissected choroidal neovascular structures.
- Compared CNV development in wild-type and MMP-9 deficient mice.
Main Results:
- MMP-9 expression was induced and temporally regulated during experimental CNV.
- MMP-9 upregulation correlated with the presence of inflammatory cells in subretinal lesions.
- Mice deficient in MMP-9 exhibited reduced development of laser-induced CNV.
Conclusions:
- MMP-9 plays a significant role in the development of choroidal neovascularization.
- Targeting MMP-9 may offer a therapeutic strategy for neovascular AMD and related conditions.